Abstract:Real-world data on acute coronary syndrome (ACS) patients who received intra-aortic balloon pump (IABP) support are limited. The objective of this study was to evaluate the characteristics of ACS patients who received IABP support from a real-world ACS registry. Patients with ACS (N = 121) who received IABP support were enrolled. Characteristics of survivors and nonsurvivors were compared at 30 days. Mortality rate of patients with ACS who received IABP was 47%. The survivors (N = 64) had less often cardiogenic shock (p < 0.001), more often IABP usage as back-up for a revascularization procedure (p = 0.002), less often resuscitation (p = 0.043), and less mechanical ventilator support (p < 0.001) than nonsurvivors. The nonsurvivors had a significantly higher leukocyte count (p = 0.033), a higher serum creatinine level (p < 0.001), a higher blood sugar on admission (p = 0.001), higher creatine kinase MB levels (p = 0.002), and a higher serum uric acid level (p < 0.001), but significantly lower left and right ventricular function (p = 0.014 and p = 0.003, respectively) than survivors. At 30 days, non-ST elevation (STE)-ACS patients had lower mortality rate than ST segment elevation myocardial infarction patients (log-rank test, p < 0.001), and non-STE-ACS patients who had not suffered from cardiogenic shock showed the lowest mortality rate (log-rank test, p < 0.001). By multivariate analysis, a heart rate ≥ 100 beats per minute before IABP insertion was the strongest predictor of 30-day mortality (hazard ratio = 5.69; 95% confidence interval, 1.49 to 21.78; p = 0.011). In ACS patients presenting with either cardiogenic shock, resuscitated, or patients who needed mechanical ventilation suffered from high mortality, despite the use of IABP. IABP appears to be safe and tended to be favorable in noncardiogenic shock ACS patients, particularly non-STE-ACS. A heart rate of ≥ 100 beats per minute prior to IABP insertion was the strongest predictor of 30-day mortality.

Survival benefit of IABP in pre- versus post-primary percutaneous coronary intervention in patients with cardiogenic shock

Application of intraaortic balloon counterpulsation during primary percutaneous coronary intervention in patients with cardiogenic shock complicating with acute myocardial infarction

Does the timing of treatment with intra-aortic balloon counterpulsation in cardiogenic shock due to ST-elevation myocardial infarction affect survival?

A multivariate and retrospective analysis of the impact of intra-aortic balloon counterpulsation in Open-Heart surgery

Factors Associated with the Prognosis of Patients with Acute Myocardial Infarction and Cardiogenic Shock

Therapeutic Efficacy of Intra-Aortic Balloon Pump Support in Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock Undergoing Percutaneous Coronary Intervention

Application of intra-aortic balloon pump in acute myocardial infarction complicared with cardiogenic shock undergoing percutaneous coronary intervention

Intra‐aortic Balloon Pump on In‐hospital Outcomes of Cardiogenic Shock: Findings from a Nationwide Registry, China

Application of Intra-Aortic Balloon Counterpulsation in Patients with Acute Myocardial Infarction

Clinical evaluation of intra aortic balloon couterpulsation in percutaneous coronary interention for patients with acute myocardial infarction combined with cardiogenic shock

INTRA-AORTIC BALLOON PUMP REDUCES 30-DAY MORTALITY IN EARLY-STAGE CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION ACCORDING TO SCAI CLASSIFICATION

The Preference, Effect, and Prognosis of Intra-Aortic Balloon Counterpulsation in Acute Myocardial Infarction Complicated by Cardiogenic Shock Patients: A Retrospective Cohort Study

The Use of Intra-aortic Balloon Pump in a Real-World Setting: A Comparison between Survivors and Nonsurvivors from Acute Coronary Syndrome Treated with IABP. The Jakarta Acute Coronary Syndrome Registry

Intra-aortic balloon counterpulsation in acute myocardial infarction: old and emerging indications

Intra-aortic Balloon Counterpulsation for Patients with Acute Myocardial Infarction and Undergoing Percutaneous Coronary Intervention: a Meta-Analysis

Prophylactic Intra-Aortic Balloon Pump Reduces C-Reactive Protein Levels And Early Mortality In High-Risk Patients Undergoing Percutaneous Coronary Intervention

Short-term Outcomes of Preoperative Intra-Aortic Balloon Pump Use in Patients Undergoing Adjunctive Coronary Endarterectomy: a Retrospective Observational Study

Preoperative prophylactic insertion of intraaortic balloon pumps in critically ill patients undergoing coronary artery bypass surgery: a meta-analysis of RCTS

Effectiveness of intra-aortic balloon pump in high-risk percutaneous coronary interventions without cardiogenic shock:A Meta-Analysis

Role of intra-aortic balloon pump counterpulsation in the treatment of acute myocardial infarction complicated by cardiogenic shock: Evidence from the Portuguese nationwide registry

Use of intraaortic balloon pump in cardiogenic shock patients